Skip to content

Effect of Nut Oatmeal Crisp on Ketogenesis in Humans: A Clinical Study

Effect of Nut Oatmeal Crisp on Ketogenesis in Humans: A Clinical Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600122811
Enrollment
Unknown
Registered
2026-04-17
Start date
2026-04-17
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Test Group:D1–D10: Investigational product (nut oatmeal crisp) plus supplementary diet, with dietary composition adhering to the Chinese Expert Consensus on Ketogenic Diet Intervention for Type 2 Diab

Sponsors

The First Hospital of Northwestern University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.Aged 20 to 45 years, inclusive, any sex; 2. No use of any medications affecting lipid metabolism or body weight within the past 3 months; 3. No adherence to special dietary regimens (e.g., ketogenic diet, low-carbohydrate diet) within the past 3 months; 4. Voluntary provision of written informed consent.

Exclusion criteria

Exclusion criteria: 1. Exclude individuals with a BMI 35 kg/m^2; 2. Exclude the following metabolic subjects (contraindicated populations): type 1 diabetes, gestational diabetes, carnitine deficiency, carnitine palmitoyltransferase I or II deficiency, carnitine transferase II deficiency, fatty acid ß-oxidation deficiency, medium-chain acyl-CoA dehydrogenase deficiency, long-chain acyl-CoA dehydrogenase deficiency, short-chain acyl-CoA dehydrogenase deficiency, long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, medium-chain 3-hydroxyacyl-CoA dehydrogenase deficiency, pyruvate carboxylase deficiency, porphyria; 3. Individuals with liver or kidney dysfunction; 4. Pregnant women, breastfeeding women, or those planning pregnancy in the near future; 5. Individuals allergic to components of the test food (such as nuts); 6. Individuals who are currently infected or in very poor physical condition; 7. Individuals currently participating in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Blood ketone concentration (ß-hydroxybutyrate);

Secondary

MeasureTime frame
Body weight, waist circumference, and BMI;

Countries

China

Contacts

Public ContactFeng Zhang

The First Hospital of Northwestern University

527100163@qq.com+86 29 8953 1040

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 1, 2026